J. Mark FitzGerald

8.8k citations

85 papers · 5.4k indexed · 3 hit papers · h-index 26

Physiology top 0.2%
- Asthma and respiratory diseases 58
Immunology and Allergy top 0.5%
- Allergic Rhinitis and Sensitization 11
Pulmonary and Respiratory Medicine top 0.5%
- Respiratory and Cough-Related Research 28
- Chronic Obstructive Pulmonary Disease (COPD) Research 17
- Inhalation and Respiratory Drug Delivery 9
Emergency Medical Services top 0.5%
Immunology top 5%
- IL-33, ST2, and ILC Pathways 5
Surgery
- Eosinophilic Esophagitis 7
General Health Professions
- Health Literacy and Information Accessibility 6

Co-authors: Mitchell Goldman Eugene R. Bleecker Peter Barker Viktoría Werkström Magnus Aurivillius Stephanie Sproule Geoffrey Gilmartin Louis‐Philippe Boulet
Cited by: Physiology Immunology and Allergy Pulmonary and Respiratory Medicine
Partner nations: Canada United States United Kingdom

In The Last Decade

J. Mark FitzGerald

83 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
2016 Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
2015 A summary of the new GINA strategy: a roadmap to asthma control

Peers

Countries citing papers authored by J. Mark FitzGerald

Since Specialization

Citations

This map shows the geographic impact of J. Mark FitzGerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark FitzGerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark FitzGerald more than expected).

Fields of papers citing papers by J. Mark FitzGerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark FitzGerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark FitzGerald. The network helps show where J. Mark FitzGerald may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Mark FitzGerald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Mark FitzGerald Line = papers co-authored together J. Mark FitzGerald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Measuring skill-based health literacy in chronic airway disease patients: the development and psychometric evaluation of the Vancouver airways health literacy tool (VAHLT) Richard E. Hohn,Jacek A. Kopec,Richard Sawatzky,Iraj Poureslami,J. Mark FitzGerald	2023	1
2	Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions Iraj Poureslami,J. Mark FitzGerald,Noah Tregobov,Roger Goldstein,M. Diane Lougheed,Samir Gupta	2022	23
3	Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry Louis‐Philippe Boulet,Marie‐Ève Boulay,Andréanne Côté,J. Mark FitzGerald,Céline Bergeron,Catherine Lemière,M. Diane Lougheed,Katherine L. Vandemheen,Shawn D. Aaron	2022	5
4	Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry Eve Denton,David Price,Trung N. Tran,Giorgio Walter Canonica,Andrew Menzies‐Gow,J. Mark FitzGerald,Mohsen Sadatsafavi,Luis Pérez de Llano,George Christoff,Anna Quinton,Chin Kook Rhee,Guy Brusselle,Charlotte Suppli Ulrik,Njira Lugogo,Fiona Hore‐Lacy,Isha Chaudhry,Lakmini Bulathsinhala,Ruth Murray,Victoria Carter,Mark Hew	2021	69
5	Efficacy and Safety of an Inhaled Anti-TSLP Antibody Fragment in Adults with Mild Atopic Asthma Gail M. Gauvreau,Jens M. Hohlfeld,Sarah Schmidt Grant,Meena Jain,Maciej Cabanski,Peter Pertel,LP Boulet,Donald W. Cockcroft,Beth E. Davis,J. Mark FitzGerald,Stephanie Korn,Oliver Kornmann,Richard Leigh,Irvin Mayers,H Watz,Jean Lecot,Paul M. O’Byrne	2020	17
6	Bridging the gap: Key informants’ perspectives on patient barriers in asthma and COPD self-management and possible solutions Jessica Shum,Iraj Poureslami,Darrin Wiebe,Iris van der Heide,Roya Hakami,Laura Nimmon,Selva Bayat,J. Mark FitzGerald	2019	6
7	Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response Amrit Singh,Casey P. Shannon,Young Woong Kim,Chen Xi Yang,Robert Balshaw,Gabriela V. Cohen Freue,Gail M. Gauvreau,J. Mark FitzGerald,Louis‐Philippe Boulet,Paul M. O’Byrne,Scott J. Tebbutt	2017	16
8	Late-breaking abstract: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma Gail M. Gauvreau,Louis‐Philippe Boulet,J. Mark FitzGerald,Donald W. Cockcroft,Beth E. Davis,Richard Leigh,Masaya Tanaka,John Fourre,Makoto Tanaka,Toshiya Nabata,Paul M. O’Byrne	2014	1
9	Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response Amrit Singh,Masatsugu Yamamoto,Jian Ruan,Jung Young Choi,Gail M. Gauvreau,Sven Olek,Ulrich Hoffmueller,Christopher Carlsten,J. Mark FitzGerald,Louis‐Philippe Boulet,Paul M. O’Byrne,Scott J. Tebbutt	2014	24
10	Peripheral Blood Gene Expression Changes during Allergen Inhalation Challenge in Atopic Asthmatic Individuals Sarah H. Y. Kam,Amrit Singh,Jian‐Qing He,Jian Ruan,Gail M. Gauvreau,Paul M. O’Byrne,J. Mark FitzGerald,Scott J. Tebbutt	2012	13
11	Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for Children Six Years of Age and Over, and Adults M. Diane Lougheed,Catherine Lemière,Sharon Dell,Francine M. Ducharme,J. Mark FitzGerald,Richard Leigh,Chris Licskai,Brian H. Rowe,Dennis Bowie,Allan B. Becker,Louis‐Philippe Boulet	2010	150
12	Antibiotic Use in Children Is Associated With Increased Risk of Asthma Fawziah Marra,Carlo A. Marra,Kathryn Richardson,Larry D. Lynd,Anita L. Kozyrskyj,David M. Patrick,William Bowie,J. Mark FitzGerald	2009	227
13	A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada. Iraj M Poureslami,Irving Rootman,Ellen Balka,Rajashree Devarakonda,James Hatch,J. Mark FitzGerald	2007	39
14	Bronchial Thermoplasty for Asthma Gerard Cox,John D. Miller,Annette McWilliams,J. Mark FitzGerald,Stephen Lam	2006	191
15	The Value of Thoracic Computed Tomography Scans in Clinical Diagnosis: A Prospective Study MARK O. TURNER,John R. Mayo,Néstor L. Müller,Michael Schulzer,J. Mark FitzGerald	2006	8
16	Reconcilable Differences Larry D. Lynd,Andrew J. Sandford,Erin Kelly,Peter D. Paré,Tony R. Bai,J. Mark FitzGerald,Aslam H. Anis	2004	25
17	Factors Associated with Tuberculin Conversion in Canadian Microbiology and Pathology Workers Dick Menzies,Anne Fanning,Lillian Yuan,J. Mark FitzGerald	2003	21
18	Magnesium sulfate is effective for severe acute asthma treated in the emergency department. J. Mark FitzGerald	2000	11
19	Psychosocial Barriers to Asthma Education J. Mark FitzGerald	1994	22
20	Abdominal Tuberculosis: A Critical Review J. Mark FitzGerald,Rebecca Menzies,R. Kevin Elwood	1991	12

About J. Mark FitzGerald

J. Mark FitzGerald is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 85 papers that have together received 5.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (58 papers), Respiratory and Cough-Related Research (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Allergic Rhinitis and Sensitization (11 papers), Inhalation and Respiratory Drug Delivery (9 papers), Eosinophilic Esophagitis (7 papers), Health Literacy and Information Accessibility (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). The work is most often cited by research in Physiology (4.1k citations), Immunology and Allergy (889 citations) and Pulmonary and Respiratory Medicine (3.2k citations). J. Mark FitzGerald has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Mitchell Goldman, Eugene R. Bleecker, Peter Barker, Viktoría Werkström, Magnus Aurivillius, Stephanie Sproule, Geoffrey Gilmartin, Louis‐Philippe Boulet, Alberto Papi and Pascal Chanez.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact